Cantor Fitzgerald Maintains Overweight Rating for Nano X Imaging: Here's What You Need To Know

Cantor Fitzgerald has decided to maintain its Overweight rating of Nano X Imaging NNOX and lower its price target from $24.00 to $18.00.

Shares of Nano X Imaging are trading up 0.0% over the last 24 hours, at $5.75 per share.

A move to $18.00 would account for a 213.04% increase from the current share price.

About Nano X Imaging

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.